Focal Interest
Focal Interest
AI Summary of Peer-Reviewed Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Publishing process signals: STRONG — reflects the venue and review process. — venue and review process.

Review compares liver-on-a-chip models for drug development

A scientist in a black shirt examines a blue microfluidic device under a microscope in a modern laboratory setting, with laboratory tools and equipment visible on the workspace.
Research area:EngineeringBiomedical EngineeringMicrofluidic and Bio-sensing Technologies

What the study found

The review says liver-on-a-chip, or LoC, models have advanced and have been useful in drug development and more advanced applications. It compares recent academic and commercial LoC models and notes that their design, cell makeup, and complexity vary.

Why the authors say this matters

The authors state that bringing advanced LoC models into preclinical workflows has great potential to decrease R&D expenses and reduce or even replace animal testing, while improving the safety and efficacy of new therapies. They also say the review may help scientists and industry professionals choose suitable models and support further advances in LoC technology.

What the researchers tested

This is a review article rather than a new experimental study. The authors overviewed recent academic and commercial liver-on-a-chip platforms, examined their designs and cellular compositions, and performed a systematic comparison of the models.

What worked and what didn't

The abstract reports that LoC technology has proven useful in drug development and more advanced applications. It also says the review evaluates the advantages and disadvantages of different levels of model complexity and discusses current challenges and future perspectives, but it does not give specific performance results for individual models.

What to keep in mind

The available summary does not list detailed limitations of the review itself. It also does not provide direct experimental data, specific model comparisons, or quantified outcomes for cost reduction, animal replacement, safety, or efficacy.

Key points

  • The review focuses on liver-on-a-chip models used in drug development and advanced applications.
  • The authors say advanced LoC models may reduce R&D costs and animal testing.
  • The paper compares academic and commercial LoC platforms by design, cell composition, and complexity.
  • The abstract says the review includes a systematic comparison and a discussion of challenges and future perspectives.
  • No specific experimental results or quantified outcomes are provided in the abstract.

Disclosure

Research title:
Review compares liver-on-a-chip models for drug development
Authors:
Zineb Benzait, Özlem Tomsuk, Aliakbar Ebrahimi, Hamed Ghorbanpoor, Ceren Özel, Reza Didarian, Bahar Demir Cevizlidere, Murat Kaya, Tamer Gur, Nigar Gasimzade, Fulya Büge Ergen, Ahmet Emin Topal, Shadab Dabagh, Roshan Javanifar, Nuran Abdullayeva, Onur Uysal, Ayla Eker Sariboyaci, Fatma Doğan Güzel, Shabir Hassan, Huseyin Avci
Institutions:
Ankara Yıldırım Beyazıt University, Ankara Yıldırım Beyazıt University, Ankara Yıldırım Beyazıt University, Bahçeşehir University, Brigham and Women's Hospital, Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Cellular Therapeutics (United Kingdom), Composite Components (Czechia), Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Eskişehir Osmangazi University, Harvard University, Institut de Recherche en Cancérologie de Montpellier, Institute of Polymers, Karadeniz Technical University, Khalifa University of Science and Technology, Middle East Technical University, National Research Council, Nello Carrara Institute of Applied Physics, Polymer Research Institute, Stem Cell Institute, Stem Cell Institute, Stem Cell Institute, Stem Cell Institute, Stem Cell Institute, Université de Montpellier, University of Konstanz, University of Pharmacy Mandalay, Yakut Scientific Research Institute of Agriculture
Publication date:
2026-02-02
DOI:
10.1021/acs.molpharmaceut.5c01122
OpenAlex record:
View
AI provenance: This post was generated by gpt-5.4-mini (OpenAI). The original authors did not write or review this post.

More posts